文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

晚期侵袭性黑色素瘤的治疗管理:新策略。

Management of Advanced Invasive Melanoma: New Strategies.

机构信息

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini, 5, 80131, Naples, Italy.

Dermatology Clinic, University of Catania, Catania, Italy.

出版信息

Adv Ther. 2023 Aug;40(8):3381-3394. doi: 10.1007/s12325-023-02555-5. Epub 2023 Jun 12.


DOI:10.1007/s12325-023-02555-5
PMID:37306810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10329960/
Abstract

The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease.

摘要

皮肤黑色素瘤 (CM) 的发病率正在上升。CM 局限于表皮内时定义为原位黑色素瘤,当不典型黑素细胞逐渐浸润真皮时定义为侵袭性黑色素瘤。CM 的治疗具有挑战性。一方面,原位黑色素瘤除了为最大限度地降低局部复发风险而进行有限的边缘缩小的二次切除外,不需要进一步治疗;另一方面,侵袭性黑色素瘤需要根据肿瘤分期制定个性化的治疗方法。因此,对于侵袭性疾病,通常需要手术和药物治疗联合。在这种情况下,对黑色素瘤发病机制的新认识导致了安全有效的治疗方法的发展,目前有几种药物正在研究中。然而,为患者提供量身定制的治疗方法需要广泛的知识。我们的文章旨在回顾当前的文献,为侵袭性黑色素瘤的治疗选择提供概述,突出可用于这些疾病患者的策略性方法。

相似文献

[1]
Management of Advanced Invasive Melanoma: New Strategies.

Adv Ther. 2023-8

[2]
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.

Acta Dermatovenerol Croat. 2018-4

[3]
Primary melanoma of the hand: An algorithmic approach to surgical management.

J Plast Surg Hand Surg. 2015

[4]
Surgical management of melanoma-in-situ using a staged marginal and central excision technique.

Ann Surg Oncol. 2009-6

[5]
Contemporary Management of Early-Stage Melanoma: A Systematic Review.

JAMA Facial Plast Surg. 2017-5-1

[6]
Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.

Can J Surg. 2003-12

[7]
Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma.

Med J Aust. 2018-2-19

[8]
Melanoma of the face: the safety of narrow excision margins.

Scand J Plast Reconstr Surg Hand Surg. 1998-3

[9]
The surgical management of "in situ" melanoma.

J Dermatol Surg Oncol. 1982-9

[10]
Clinical diagnosis and therapy of cutaneous melanoma in situ.

Cancer. 1996-3-1

引用本文的文献

[1]
Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma.

Front Oncol. 2025-6-17

[2]
Primary Cutaneous Rhabdomyosarcomatous Melanomas-A Report of Two Cases and Literature Review.

Diagnostics (Basel). 2025-5-28

[3]
Anoectochilusroxburghii extract down-regulates METTL3 to reduce RNA mA on WNT pathway and inhibit melanoma cancer cell metastasis.

J Cancer. 2024-8-13

[4]
Exploring the Surface: Sampling of Potential Skin Cancer Biomarkers Kynurenine and Tryptophan, Studied on 3D Melanocyte and Melanoma Models.

Biomolecules. 2024-7-9

[5]
Unaddressed Challenges in the Treatment of Cutaneous Melanoma?

Medicina (Kaunas). 2024-5-28

[6]
Blood Vitamin C Levels of Patients Receiving Immunotherapy and Relationship to Monocyte Subtype and Epigenetic Modification.

Epigenomes. 2024-4-30

[7]
Melatonin/Sericin Wound Healing Patches: Implications for Melanoma Therapy.

Int J Mol Sci. 2024-4-29

[8]
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation.

Cancers (Basel). 2024-4-29

[9]
The Past, the Present and the Future of Teledermatology: A Narrative Review.

Clin Cosmet Investig Dermatol. 2024-3-21

[10]
Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.

Int J Mol Sci. 2024-3-4

本文引用的文献

[1]
Mohs Micrographic Surgery.

Dermatol Clin. 2023-1

[2]
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic.

Dermatol Ther. 2022-11

[3]
Effects of COVID-19 pandemic on malignant melanoma diagnosis.

J Eur Acad Dermatol Venereol. 2023-1

[4]
The Treatment of Advanced Melanoma: Therapeutic Update.

Int J Mol Sci. 2022-6-7

[5]
Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction.

Int J Mol Sci. 2022-5-11

[6]
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.

Eur J Cancer. 2022-7

[7]
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.

Eur J Cancer. 2022-7

[8]
Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas.

Oncologist. 2022-6-8

[9]
Teledermatology: A useful tool also after COVID-19 era?

J Cosmet Dermatol. 2022-6

[10]
Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.

Cancer Immunol Res. 2022-5-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索